GRDX

GridAI Technologies Corp.

$5.55

-0.18%

SectorHealthcareIndustryBiotechnologyCountryUnited Kingdom

Overview AI Brief ChartChart & Performance Financials ExposureRevenue Exposure FilingsFilings & Red Flags ScoresScores & Valuation News Analysts InsidersInsiders & Short Interest Ownership

GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.

Source: Yahoo Finance

Market Cap$49.3M

Dividend Yield0.00%

Beta0.50

AI summary

Price & performance

1M+70.1%

3M+85.2%

YTD+13.5%

1Y+42.7%

52-week range—

Beta0.50

Full chart and returns against a benchmark

Q-Score

35/ 100

Quality against peers; 50 is the peer median.

Growth29

Risk31

Performance58

Valuation42

Profitability24

Leverage33

Sentiment—

Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$36.3K

Net income-$6.4M

Net margin—

Historical fundamentals

Red flags in filings

5active red flags

Going-concern doubtMay 1, 2026

Material weakness in controlsMay 1, 2026

Late filing noticeAug 14, 2026

Filings, findings and the timeline

Revenue exposure

0%of revenue from outside the US

United States100%

Regions, segments, customers and suppliers

Valuation

GRDXIndustryP/E—89.69P/S—11.88EV/EBITDA—67.10P/B3.326.22PEG—4.02

Dividend yield0.00%

Every valuation metric

Historical Fundamentals

Revenue

Net Income

Showing the last 4 periods. Pro adds the full annual and quarterly history and 20+ more metrics to chart.

Latest Results

The latest fiscal year and quarter, each against the same period a year earlier, from SEC filings.

Metric	FY 2025	vs a year before	Q2 2026	vs a year before
Revenue	$36.3K	—	$85.9K	—
Net Income	-$6.4M	—	-$13M	—

Q-Scores

OverallCombines the categories below, except Sentiment

Industry 5735

Growth

Industry 7929

Risk

Industry 5531

Performance

Industry 6658

Valuation

Industry 2542

Profitability

Industry 4724

Leverage

Industry 6833

Key Metrics

Fundamentals: trailing twelve months to Jun 2026, from the latest 10-K and 10-Qs.

Market Beta (5-factor)

IM 0.72SM 0.780.39

Market Cap

49.3M

Dividend Yield

IM 0.00%SM 0.00%0.00%

Volume

IM 693.1KSM 741.7K116.9K

Industry Market Share

0.00%

Sector Market Share

0.00%

IM industry median · SM sector median: the typical company the value is compared with. The /100 is its score against those peers.

Comparable Companies

The companies closest in size in Biotechnology (filled from its sector when there are few), with the median and rank across all 576 in the industry.

Company	Market cap	P/E	EV/EBITDA	P/S	P/B	FCF yield	Revenue growth	ROE	Debt/equity
GRDXGridAI Technologies Corp.	$49.3M	—	—	—	3.3	-16.5%	—	-145.3%	0.0
HYFTMindWalk Holdings Corp.	$49M	—	—	2.4	4.4	-18.4%	109.9%	-90.5%	0.0
MREOMereo BioPharma Group plc	$49M	—	—	61.2	2.1	-45.1%	60.0%	-113.6%	0.0
ATNMActinium Pharmaceuticals, Inc.	$50M	4.4	1.3	—	1.6	-45.5%	—	37.3%	0.0
GANXGain Therapeutics, Inc.	$48.4M	—	—	—	4.8	-35.2%	—	-177.2%	0.0
PLRXPliant Therapeutics, Inc.	$48.2M	—	—	—	0.3	-147.2%	—	-62.8%	0.0
HOWLWerewolf Therapeutics, Inc.	$48.1M	—	—	—	3.0	-62.7%	—	-212.5%	2.0
INKTMiNK Therapeutics, Inc.	$52.2M	—	—	—	—	-13.1%	—	—	—
RNTXRein Therapeutics Inc.	$52.3M	—	—	—	0.9	-36.0%	—	-90.1%	0.0
Industry median		11.8	20.0	7.8	2.2	-22.0%	13.0%	-62.6%	0.0
GRDX percentile		—	—	—	60th	58th	—	22nd	39th